A Risk-Based Approach to Immunogenicity Concerns of Therapeutic Protein Products.

Autor: Rosenberg, Amy S.1 amy.rosenberg@fda.gov, Worobec, Alexandra2 alexandra.worobec@fda.go
Zdroj: BioPharm International. Nov2004, Vol. 17 Issue 11, p22-26. 4p.
Databáze: Business Source Ultimate